UK markets open in 1 hour 27 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
18.74-0.54 (-2.80%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,613
1,613
1,422
2,916
3,613
Operating expenses
Research development
2,748
2,748
10,030
9,014
10,373
Selling general and administrative
7,205
7,205
10,116
7,746
5,749
Total operating expenses
11,894
11,894
21,942
18,422
15,856
Operating income or loss
-10,281
-10,281
-20,520
-15,506
-12,243
Interest expense
21.607
21.607
48.897
63.012
69.502
Total other income/expenses net
-317.285
-317.285
-264.36
211.693
-581.128
Income before tax
-10,556
-10,556
-20,804
-15,352
-12,859
Income tax expense
0
0
0
0
0
Income from continuing operations
-10,556
-10,556
-20,804
-15,352
-12,859
Net income
-10,556
-10,556
-20,804
-15,352
-12,859
Net income available to common shareholders
-10,556
-10,556
-20,804
-15,352
-12,859
Basic EPS
-18.00
-
-55.20
-54.00
-57.60
Diluted EPS
-18.00
-
-55.20
-54.00
-57.60
Basic average shares
558.17
-
376.541
284.331
222.348
Diluted average shares
558.17
-
376.541
284.331
222.348